KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
002737 Sunflower Pharmaceutical Group
- 20.90
- -0.44-2.06%
Not Open Dec 13 15:00 CST
12.21BMarket Cap14.28P/E (TTM)
21.38High20.90Low105.35KlotVolume21.24Open21.34Pre Close222.65MTurnover1.80%Turnover Ratio10.91P/E (Static)584.00MShares29.5952wk High2.72P/B12.21BFloat Cap18.2252wk Low23.47Limit Up584.00MShs Float31.70Historical High19.21Limit Down2.25%Amplitude4.53Historical Low1.50Dividend TTM21.13Avg Price54.18KlotAsk7.18%Div YieldTTM100Lot Size49.89KlotBid
Sunflower Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -29.95%2.97B | -16.69%2.53B | -14.01%1.52B | 11.89%5.7B | 31.14%4.24B | 34.89%3.03B | 47.31%1.77B | 14.20%5.09B | 7.11%3.23B | 7.01%2.25B |
| Operating revenue | -29.95%2.97B | -16.69%2.53B | -14.01%1.52B | 11.89%5.7B | 31.14%4.24B | 34.89%3.03B | 47.31%1.77B | 14.20%5.09B | 7.11%3.23B | 7.01%2.25B |
| Other operating revenue | ---- | -38.21%5.05M | ---- | 32.47%14.62M | ---- | 3.99%8.18M | ---- | 68.42%11.03M | ---- | 63.61%7.86M |
| Total operating cost | -27.76%2.35B | -15.38%1.92B | -5.17%1.2B | 10.86%4.5B | 25.68%3.26B | 29.14%2.27B | 36.73%1.26B | 11.20%4.06B | 2.15%2.59B | 1.58%1.76B |
| Operating cost | -19.85%1.42B | -9.69%1.12B | -8.08%656.37M | 15.75%2.49B | 33.61%1.77B | 34.56%1.24B | 46.35%714.03M | 18.46%2.15B | 3.30%1.32B | 4.41%921.39M |
| Operating tax surcharges | -19.20%38.71M | -11.76%30.21M | -11.97%16.12M | -1.30%68.5M | 18.11%47.9M | 29.88%34.23M | 4.80%18.31M | 5.87%69.4M | -3.92%40.56M | -17.03%26.36M |
| Operating expense | -46.47%540.06M | -28.09%517.72M | -0.76%395.1M | 7.24%1.37B | 22.24%1.01B | 35.47%719.95M | 23.95%398.13M | 8.40%1.27B | -2.44%825.41M | -7.45%531.43M |
| Administration expense | -17.37%300.62M | -9.24%221.08M | 1.09%118.84M | -0.71%472.84M | 14.13%363.82M | 2.16%243.6M | 36.86%117.56M | 1.95%476.25M | 12.47%318.78M | 18.02%238.45M |
| Financial expense | 12.80%-21.73M | -25.11%-20.96M | -99.69%-11.11M | -186.50%-31.96M | -157.94%-24.92M | -111.28%-16.76M | -114.34%-5.57M | -12.53%-11.16M | -5.51%-9.66M | -2.26%-7.93M |
| -Interest expense (Financial expense) | -63.67%1.62M | -91.21%354.12K | -93.66%203.49K | -38.67%5.97M | -13.00%4.46M | 46.96%4.03M | 46.25%3.21M | -4.51%9.73M | -32.88%5.12M | -39.34%2.74M |
| -Interest Income (Financial expense) | 16.96%-24.13M | -3.42%-21.71M | -24.83%-11.1M | -81.33%-38.39M | -92.54%-29.06M | -92.28%-21M | -90.85%-8.89M | -3.77%-21.17M | 11.28%-15.09M | 12.20%-10.92M |
| Research and development | -16.47%79.43M | 8.91%51.43M | 8.63%22.99M | 35.97%128.65M | 0.33%95.1M | 1.32%47.23M | 47.63%21.17M | -28.36%94.61M | -0.17%94.78M | 0.80%46.61M |
| Credit Impairment Loss | -1,608.71%-21.29M | -113.14%-7.92M | -82.60%-2.99M | 148.91%2.55M | 139.26%1.41M | -256.89%-3.72M | -301.37%-1.64M | 80.66%-5.22M | 49.24%-3.59M | 80.52%-1.04M |
| Asset Impairment Loss | -2,357.81%-3.65M | -248.57%-992.19K | 30.50%-1.86M | 96.67%-978.23K | 114.11%161.65K | 897.16%667.84K | -1,274.68%-2.68M | 9.43%-29.36M | -4,335.22%-1.15M | -107.42%-83.78K |
| Other net revenue | 90.74%128.56M | -44.12%28.65M | 40.96%18.36M | 251.18%162.66M | 69.55%67.4M | 22.80%51.27M | 5.83%13.02M | -35.41%46.32M | 367.84%39.75M | 284.00%41.75M |
| Fair value change income | 74.87%-3.57M | 20.06%-12.29M | -133.08%-5.36M | 15.12%-16.39M | 38.20%-14.22M | 5.87%-15.37M | 77.09%-2.3M | -823.65%-19.31M | ---23.01M | ---16.33M |
| Invest income | -49.80%12.79M | -62.63%9.23M | 98.35%5.41M | 400.16%46.96M | 89.09%25.47M | 68.98%24.7M | -26.19%2.73M | -60.36%9.39M | 150.92%13.47M | 192.92%14.62M |
| -Including: Investment income associates | 34.80%-1.31M | 27.98%-827.51K | -22.88%-464.04K | -88.04%-2.51M | -58.66%-2.01M | -43.31%-1.15M | 4.74%-377.62K | -79.18%-1.33M | ---1.26M | ---801.81K |
| Asset deal income | -117.94%-185.1K | -99.99%94.21 | --0 | -56.52%3.23M | 382.89%1.03M | 632.93%907.65K | 433.62%626.04K | -84.44%7.43M | 100.55%213.7K | 100.32%123.84K |
| Other revenue | 169.80%144.47M | -7.86%40.62M | 42.22%23.16M | 52.64%127.28M | -0.50%53.55M | -0.86%44.08M | -6.88%16.28M | 46.32%83.38M | 109.97%53.82M | 191.04%44.47M |
| Operating profit | -28.98%741.19M | -22.03%637.11M | -34.31%338.23M | 25.98%1.37B | 54.36%1.04B | 52.85%817.12M | 79.68%514.91M | 22.57%1.08B | 46.40%676.12M | 52.73%534.6M |
| Add:Non operating Income | 330.31%5.74M | 367.21%4.48M | 174.20%333.18K | -6.61%2.59M | -26.91%1.33M | 1.65%959.16K | -84.90%121.51K | -83.12%2.78M | -98.21%1.83M | -99.06%943.59K |
| Less:Non operating expense | -70.51%2.57M | -37.92%1.39M | 272.37%938.18K | 119.89%14.65M | 64.49%8.72M | -51.52%2.24M | -58.05%251.95K | -6.70%6.66M | -30.67%5.3M | -25.62%4.63M |
| Total profit | -28.17%744.37M | -21.53%640.2M | -34.41%337.62M | 25.31%1.35B | 54.06%1.04B | 53.67%815.84M | 79.51%514.78M | 20.86%1.08B | 20.99%672.64M | 19.58%530.92M |
| Less:Income tax cost | -6.96%138.85M | -9.51%123.92M | -15.23%67.32M | 10.77%189.83M | 9.87%149.24M | 30.08%136.93M | 51.37%79.42M | 29.66%171.37M | 31.64%135.83M | 17.32%105.27M |
| Net profit | -31.74%605.51M | -23.95%516.28M | -37.91%270.3M | 28.05%1.16B | 65.25%887.06M | 59.50%678.91M | 85.81%435.36M | 19.33%909.73M | 18.56%536.81M | 20.16%425.65M |
| Net profit from continuing operation | -31.74%605.51M | -23.95%516.28M | -37.91%270.3M | 28.05%1.16B | 65.25%887.06M | 59.50%678.91M | 85.81%435.36M | 19.33%909.73M | 18.56%536.81M | 20.16%425.65M |
| Less:Minority Profit | -47.93%18.68M | -26.49%29.95M | -48.27%15.12M | 7.72%45.8M | 29.31%35.87M | 66.80%40.75M | 93.16%29.23M | -26.21%42.51M | -46.72%27.74M | -47.96%24.43M |
| Net profit of parent company owners | -31.06%586.84M | -23.79%486.33M | -37.17%255.18M | 29.05%1.12B | 67.20%851.19M | 59.06%638.16M | 85.30%406.14M | 23.06%867.22M | 27.05%509.07M | 30.56%401.22M |
| Earning per share | ||||||||||
| Basic earning per share | -31.97%1 | -24.55%0.83 | -37.14%0.44 | 29.73%1.92 | 67.05%1.47 | 59.42%1.1 | 84.21%0.7 | 22.31%1.48 | 27.54%0.88 | 30.19%0.69 |
| Diluted earning per share | -31.51%1 | -23.85%0.83 | -37.14%0.44 | 29.73%1.92 | 67.82%1.46 | 57.97%1.09 | 84.21%0.7 | 22.31%1.48 | 26.09%0.87 | 30.19%0.69 |
| Other composite income | 820.00%120.56K | -91.86%17.04K | 1,516.50%32.76K | 65.69%-45.86K | 109.17%13.1K | 328.17%209.29K | 88.23%-2.31K | 55.83%-133.66K | 9.92%-142.83K | 11.39%-91.73K |
| Other composite income of parent company owners | 820.00%84.39K | -94.63%11.92K | 839.98%22.93K | 65.69%-32.1K | 109.17%9.17K | 446.16%222.27K | 77.48%-3.1K | 55.83%-93.56K | 9.92%-99.98K | 11.39%-64.21K |
| Other composite income of minority owners | 820.00%36.17K | 139.39%5.11K | 1,150.00%9.83K | 65.69%-13.76K | 109.17%3.93K | 52.86%-12.97K | 113.33%786.24 | 55.83%-40.1K | 9.92%-42.85K | 11.39%-27.52K |
| Total composite income | -31.73%605.63M | -23.97%516.3M | -37.91%270.34M | 28.07%1.16B | 65.29%887.07M | 59.58%679.12M | 85.83%435.36M | 19.36%909.6M | 18.57%536.67M | 20.17%425.55M |
| Total composite income of parent company owners | -31.05%586.92M | -23.82%486.34M | -37.16%255.21M | 29.06%1.12B | 67.24%851.2M | 59.14%638.38M | 85.31%406.13M | 23.08%867.13M | 27.06%508.97M | 30.57%401.15M |
| Total composite income of minority owners | -47.83%18.71M | -26.46%29.96M | -48.24%15.13M | 7.79%45.78M | 29.53%35.87M | 66.93%40.73M | 93.24%29.23M | -26.16%42.47M | -46.75%27.7M | -47.99%24.4M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
